Hebel Consulting
The Hebel Consulting Group is a global company providing consulting services for the biopharmaceutical industry supported by offices in the US and Germany.Customer Support
We create a unique process for each client to ensure that business objectives are met and success is achieved.
Our Core Values
Contact Info
- 22 Wingreen Loop, The Hills, TX 78738. USA
- (713)857-4103
- (281)-799-3283
- info@hebelconsulting.com
Blog (Timeline Style)
- July 2017
- January 2016
-
By Mark Terry, BioSpace.com Breaking News Staff BioSpace (DHX) is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States. Once BioSpace sorted the companies into that group, they were then weighted by a number of […]
Read More - May 2015
-
from GenomeWeb NEW YORK (GenomeWeb) – Aiming to simplify and improve the targeted sequencing workflow, LC Sciences is building out its VariantPro multiplexing PCR technology with an eye on a fourth quarter launch. The company is in the midst of testing the technology and recently sent out a call for beta testers to, among other […]
Read More -
Today, the Hebel Consulting Group welcomes Prisitine as its newest partner. Pristine develops smart glasses and video collaboration technologies for the life sciences. Wearable technology is changing the way we work. Smart glasses like Google Glass, Vuzix, and others are empowering a new generation of mobile workers to become wearable workers. When time to resolution (TTR) […]
Read More - March 2015
-
The problem is that peptides are usually too small and too easily digested by digestive enzymes. We can ‘cut and paste’ genes of interest using a LEGO-like platform technology to produce multi-domain fusion proteins capable of being orally administered. Using powerful bioinformatics search engines, we select compelling candidate genes with the result of a higher […]
Read More - January 2015
-
from GenomeWeb NEW YORK (GenomeWeb) – AltheaDx has raised the target amount on its proposed initial public offering to about $74.3 million from $69 million, it disclosed in an amended prospectus filed with the US Securities and Exchange Commission last week. The company said that it expects to fetch between $12 and $14 per share […]
Read More - November 2014
-
From Genetic Engineering and Biotechnology News Before humankind can explore strange new worlds and seek out new life and new civilizations, it will have to deal with a weighty down-to-earth constraint: launchpad economics. Every unit of mass of payload that launched into space requires the support of an additional 99 units of mass, with “support” encompassing […]
Read More -
from Pharmatimes by Kevin Grogan The European Commission and the European pharmaceutical industry have linked up to launch a 280 million euro call for proposals under the Innovative Medicines Initiative to boost Ebola research. The funding will cover “urgent actions addressing the current epidemic and put in place a long-term strategy to manage any future […]
Read More - October 2014
-
Ajinomoto Althea, Inc. (“Althea”), a leading provider of biopharmaceutical contract development and manufacturing services has announced that it has officially received its European GMP certificate issued by the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA conducted an on-site inspection on June 19, 2014 that yielded no critical or major observations. This certification provides […]
Read More -
AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into a clinical study collaboration with biopharmaceutical company Incyte Corporation. The Phase I/II oncology study will evaluate the efficacy and safety of MedImmune’s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with Incyte’s oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360. Both MEDI4736 and […]
Read More
Parse error: syntax error, unexpected $end in /home/hebelcon/public_html/wp-content/themes/smarton/library/includes/wp-pagenavi.php on line 145